Aster DM Healthcare (India), a prominent private healthcare service provider, is strategically expanding its presence in the northern and western regions of India. To achieve its ambitious growth plans, the company is actively exploring inorganic opportunities, leveraging internal accruals, particularly boosted by the sale of its Gulf Cooperation Council (GCC) business. Additionally, Aster is engaging in discussions with private equity players for potential partnerships.
In the next two to three years, Aster aims to increase its total bed count in India to over 6,000. This expansion includes the development of Aster Capital in Trivandrum, featuring 350-plus beds in the initial phase by FY26, and Aster MIMS Kasargod, with 200-plus beds. Currently operating with 4,800 beds, Aster plans to infuse an additional 1,500 beds, requiring an investment of Rs 850-900 crore. The company also envisions adding bed capacity to existing hospitals, such as Medcity, MIMS Kannur (with approximately 100 beds each), and Aster Whitefield (with 159 beds).
Aster's current presence spans five states in the south, encompassing 19 hospitals, 13 clinics, 226 pharmacies, and 251 patient experience centers. The company's hospitals are strategically located in Kochi, Kolhapur, Kozhikode, Kottakkal, Bengaluru, and Hyderabad. Recognizing the potential of Maharashtra, Pune, and Uttar Pradesh, especially in light of the increasing trend of North-based healthcare groups venturing into the region, Aster is keen on further expansion.
In a significant move last year, Aster DM Healthcare's subsidiary announced the sale of its stake in Aster DM Healthcare FZC to Alpha GCC, providing crucial funding for the company's ongoing growth initiatives.
News by Rahul Yelligetti